Table 1 Clinical manifestations.

		Number (n = 51)	%	LB‐IgG positive	LB‐IgM positive	Systemic features LB	LB‐IgM and systemic LB
Meningeal symptoms:
Headache or Meningism		47	92	30	34	23	17
CSF pleocytosis		42	95*
Lymphocytic		26	62†
Polymorphonuclear		8	19†
mixed		8	19†
Neurological features:
Tremor		22	43	15	10	4	4
Nystagmus		12	24	8	7	2	2
Muscle weakness		21	41	13	16	11	8
Flaccid paresis arms and shoulders		14	28	10	11	6	6
Flaccid paresis legs		8	16	6	7	5	4
Spastic paresis		6	12	3	5	4	3
Bulbar or respiratory dysfunction		3	6	2	1	2	1
Facial palsy		3	6	1	3	1	1
Oculomotor disturbances		2	4	1	1
Distal polyneuropathy		4	8	3	2	2	2
Migrating, radicular, limb pains		21	41	13	16	10	8
Systemic features:
Biphasic fever		28	55	23	17	12	8
Early local erythema (>5 cm)		7	14	4	4
Erythema chronicum migrans		1	2	1	1
Joint involvement		9	18	6	7
Arthralgias		7	14	4	5
Swelling		2	4	2	2
Atrio‐ventricular block		5	10	5	3
His Bundle block		10	20	5	8
Seropositivity:
TBE	IgM	51	100	33	35	25	18
Borrelia	IgM	35	69			18
	IgG	33	65			15
	IgM and IgG	18	35			7

CSF, cerebrospinal fluid; Ig, immunoglobulin; LB, Lyme borreliosis.

*Of the 44 lumbar punctured.

†Of those with pleocytic CSF.